Advancing Cancer Vaccines with Radionuclide Imaging.

Cancer vaccines are emerged as a beacon of hope in the fight against cancer. However, the lack of effective methods to directly observe their in vivo behavior and monitor therapeutic responses hinders their translation into clinical settings. Radionuclide imaging allows for non-invasive and real-time visualization of vaccine biodistribution and immunological response, offering valuable insights into the effectiveness of cancer vaccines and aiding in patient stratification. In this review, the latest advances and potential applications of radionuclide imaging in cancer vaccines are discussed, with a specific focus on strategies for visualizing the spatiotemporal distribution of vaccines in vivo and monitoring treatment efficacy. The challenges and considerations for implementing these techniques in clinical practice are also highlighted, aiming to inform and guide future research in this field. © 2024 Wiley‐VCH GmbH.

Citation

Sixuan Cheng, Xingru Long, Yongxue Zhang, Xiaoli Lan, Dawei Jiang. Advancing Cancer Vaccines with Radionuclide Imaging. Small (Weinheim an der Bergstrasse, Germany). 2025 Jan;21(2):e2406950

Mesh Tags

Substances

PMID: 39530610

search → result